A perfect storm: Covid-19 viral vector manufacturing adds further burden to CAR-T development
Despite a slow return to normal, the impact of Covid-19 is still being felt across the CAR-T cell therapy industry.
By
Despite a slow return to normal, the impact of Covid-19 is still being felt across the CAR-T cell therapy industry.
ByValneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
ByThe structural complexity of modern biologics presents packaging manufacturers with new challenges.
ByInfusion therapy has seen a rise in popularity as a drug delivery system in recent years, mainly due to its…
Delivering therapeutic drugs by applying substances to the skin is a practise that dates back thousands of years, but is…
Lloyd’s Register, an independent global assurance firm, has facilitated a best-practice standard for Responsible Plastic Management (RPM) that will allow…
Pharmaceutical manufacturer Romaco Siebler and foil specialist Huhtamaki are set to launch recyclable unit dose packaging. For sustainability advocates, this…
ByResearchers at the University of Michigan in the US have developed a nanoparticles injection to prevent the immune system from…
Thank you for subscribing to Pharmaceutical Technology